Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise
Part of paid clinical trials in Chapel Hill, North Carolina.
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Study ID
- NCT07313306
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- The Real and Heel (GRH) — BEHAVIORALThe Get Real and Heel (GRH) program is a 16-week exercise intervention developed at the University of North Carolina at Chapel Hill (UNC).
Study Details
This study will examine unmet exercise needs among patients with metastatic breast cancer (MBC) at UNC and assess whether participation in Get Real and Heel (GRH) can increase physical activity. The proposed research aims to improve multiple domains of well-being, quality of life, physical function, social support and reduce social isolation through a community based exercise intervention. By leveraging underutilized University of North Carolina Chapel Hill (UNC) resources, this work seeks to reduce barriers to accessibility, awareness, and appropriateness of exercise programming for this underserved population. Findings will help close the gap between patients' exercise needs, interest, and participation, with potential benefits for symptoms, functioning, and quality of life.
Key Dates
- Start date
- Dec 15, 2025
- Status verified
- Jan 2026
- Primary completion
- Jul 1, 2028
- Completion
- Jul 1, 2028
Study Design
- Enrollment
- 50 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Metastatic breast cancer (MBC) receive Get Real and Heel (GRH)Participants will receive Get Real and Heel (GRH) exercise program.
Primary Outcome Measure
Feasibility of referral to Get Real and Heel [ Time Frame: Up to 16 weeks ]
Central Contacts
- Kristen Jarman919-984-0000
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Lineberger Comphrehensive Cancer Center at University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27599 | Sasha Knowlton Sasha E Knowlton, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Chapel Hill, NC
Related Studies
- Correlation of Molecular Markers With Response to Therapy and Breast Cancer BehaviorRecruiting · UNC Lineberger Comprehensive Cancer Center · Chapel Hill, North Carolina
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal MetastasisPHASE2 · Recruiting · Wake Forest University Health Sciences · Baltimore, Maryland